Intron A - Rebetol (Ribavirin, Interferon Alfa-2b, Recombinant) Drug Center: Guide to Drug Information for Professionals, Patients and Caregivers at RxList

Pill Identifier Search

May 27, 2012

Intron A Rebetol

Hepatitis C »

Hepatitis C infection facts

HCV is one of several viruses that cause hepatitis (inflammation of the liver).
Up to 85% of individuals who are initially (acutely) infected with HCV will fail to eliminate the virus and will become chronically infected.
HCV is spread most commonly through inadvertent exposure to infected blood. Intravenous drug abuse is the most common mode of transmission. The risk of acquiring HCV through sexual contact is low.
Generally, patients do not develop symptoms of chronic infection with HCV until they have extensive scarring of the liver (cirrhosis). Some individuals, however, may have fatigue and other non-specific symptoms in the absence of cirrhosis. A minority of patients with HCV have symptoms from organs outside of the liver.
In the U.S., Infection with HCV is the most common cause of chronic hepatitis and the most common reason for liver transplantation.
...

Read the Hepatitis C article »

Intron A - Rebetol

Hepatitis Slideshow Pictures

Digestive Disease Myths Slideshow Pictures

Infectious Mononucleosis Slideshow Pictures

font size

Intron A Rebetol Drug Center

What is Prescribing information?

The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.

Intron A Rebetol Prescribing Information: Indications & Dosage

REBETOL (ribavirin, USP) Capsules is indicated in combination with INTRON A (interferon alfa-2b, recombinant) Injection for the treatment of chronic hepatitis C in patients with compensated liver disease previously untreated with alpha interferon or who have relapsed following alpha interferon therapy.

Description of Clinical Studies

Previously Untreated Patients

Adults with compensated chronic hepatitis C and detectable HCV RNA (assessed by a central laboratory using a research based RT-PCR assay) who were previously untreated with alpha int...

Read the complete drug monograph for Intron A Rebetol »